Cargando…
Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease de...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/ https://www.ncbi.nlm.nih.gov/pubmed/27437705 http://dx.doi.org/10.1371/journal.pone.0159318 |
_version_ | 1782443819916066816 |
---|---|
author | Fengler, Sophie Kessler, Josef Timmermann, Lars Zapf, Alexandra Elben, Saskia Wojtecki, Lars Tucha, Oliver Kalbe, Elke |
author_facet | Fengler, Sophie Kessler, Josef Timmermann, Lars Zapf, Alexandra Elben, Saskia Wojtecki, Lars Tucha, Oliver Kalbe, Elke |
author_sort | Fengler, Sophie |
collection | PubMed |
description | BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. METHODS: In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the subtests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. RESULTS: Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. CONCLUSION: This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA’s actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system. |
format | Online Article Text |
id | pubmed-4954721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49547212016-08-08 Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting Fengler, Sophie Kessler, Josef Timmermann, Lars Zapf, Alexandra Elben, Saskia Wojtecki, Lars Tucha, Oliver Kalbe, Elke PLoS One Research Article BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. METHODS: In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the subtests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. RESULTS: Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. CONCLUSION: This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA’s actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system. Public Library of Science 2016-07-20 /pmc/articles/PMC4954721/ /pubmed/27437705 http://dx.doi.org/10.1371/journal.pone.0159318 Text en © 2016 Fengler et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Fengler, Sophie Kessler, Josef Timmermann, Lars Zapf, Alexandra Elben, Saskia Wojtecki, Lars Tucha, Oliver Kalbe, Elke Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
title | Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
title_full | Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
title_fullStr | Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
title_full_unstemmed | Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
title_short | Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
title_sort | screening for cognitive impairment in parkinson's disease: improving the diagnostic utility of the moca through subtest weighting |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/ https://www.ncbi.nlm.nih.gov/pubmed/27437705 http://dx.doi.org/10.1371/journal.pone.0159318 |
work_keys_str_mv | AT fenglersophie screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT kesslerjosef screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT timmermannlars screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT zapfalexandra screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT elbensaskia screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT wojteckilars screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT tuchaoliver screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting AT kalbeelke screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting |